Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2022-Q3
добавлен 07.11.2022
Concert Pharmaceuticals Мультипликаторы 2011-2024 | CNCE
Мультипликаторы по годам Concert Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.3 | -4.4 | -3.3 | -6.0 | 5.0 | -3.9 | 13.4 | -6.6 | - | - | - |
P/S |
- | 41.3 | 240.0 | 31.7 | 3.3 | 1141.0 | 4.8 | 24.4 | - | - | - |
EPS |
-2.3 | -2.4 | -3.3 | -2.4 | 4.2 | -2.3 | 1.1 | -2 | -5.0 | -16.1 | - |
EV (Enterprise Value) |
14.7 млн | 278 млн | 241 млн | 341 млн | 464 млн | 173 млн | 247 млн | 225 млн | 142 млн | 132 млн | 136 млн |
EBITDA per Share |
-2.21 | -2.32 | -3.32 | -2.33 | 4.14 | -2.26 | 1.21 | -1.87 | - | - | - |
EV/EBITDA |
-0.2 | -3.5 | -2.6 | -5.8 | 4.8 | -3.1 | 9.0 | -6.9 | - | - | - |
PEG |
0.01 | -1.02 | 0.09 | 0.04 | 0.02 | 0.01 | 0.09 | 0.02 | - | - | - |
P/B |
0.9 | 2.5 | 2.5 | 2.0 | 2.4 | 2.3 | 2.5 | 3.8 | - | - | - |
P/CF |
-1.9 | -4.7 | -5.2 | -6.6 | 4.7 | -4.3 | 14.6 | -6.8 | - | - | - |
ROE % |
-71.33 | -57.00 | -77.04 | -33.40 | 48.69 | -59.26 | 18.50 | -57.82 | - | - | - |
ROA % |
-48.42 | -46.94 | -56.86 | -29.10 | 45.17 | -50.52 | 16.45 | -37.53 | - | - | - |
ROCE % |
-69.06 | -48.73 | -65.73 | -30.24 | 45.13 | -53.96 | 17.67 | -46.48 | - | - | - |
Current Ratio |
3.1 | 14.0 | 6.8 | 20.6 | 31.9 | 17.5 | 21.7 | 4.4 | - | - | - |
DSO |
- | 146.7 | 112.5 | 575.8 | 2.0 | 400.7 | 1.4 | 54.6 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Concert Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.58 | - | -1.03 | - | -0.78 | 0.16 | -0.67 | -0.69 | -0.6 | -0.41 | -0.7 | -0.86 | -0.72 | -0.78 | -0.93 | -0.89 | -0.74 | -0.57 | -0.19 | -0.26 | 5.61 | -0.58 | -0.6 | -0.54 | -0.51 | -0.6 | -0.63 | 0.03 | -0.39 | 1.89 | -0.48 | -0.49 | -0.43 | -0.45 | -0.76 | -4.64 | -5.59 | - | -1.46 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.58 | - | -0.97 | - | -0.75 | 0.18 | -0.7 | -0.67 | -0.58 | -0.39 | -0.63 | -0.88 | -0.71 | -0.78 | -0.85 | -0.86 | -0.7 | -0.59 | -0.15 | -0.55 | 5.84 | -0.55 | -0.59 | -0.54 | -0.49 | -0.59 | -0.62 | 0.03 | -0.37 | 1.93 | -0.46 | -0.48 | -0.37 | -0.39 | -0.67 | -4.3 | -4.73 | 7.82 | -0.61 | - | - | - | - | - | - | - | - |
ROE % |
-89.39 | -116.29 | -121.51 | -98.66 | -42.36 | -59.43 | -46.94 | -61.27 | -57.00 | -60.13 | -62.65 | -71.14 | -77.04 | -69.28 | -62.71 | -52.25 | -33.40 | -24.06 | 51.50 | 52.82 | 48.69 | 37.71 | -40.76 | -49.83 | -59.26 | -44.66 | -37.94 | 9.18 | 18.50 | 1.70 | -6.04 | -52.03 | -57.82 | -36.26 | -15.62 | -8.86 | 5.40 | 0.13 | -6.23 | 1.59 | - | - | - | - | - | - | - | - |
ROA % |
-75.20 | -96.01 | -70.77 | -67.12 | -33.35 | -47.41 | -38.48 | -50.28 | -46.94 | -47.79 | -48.42 | -53.84 | -56.86 | -52.79 | -49.31 | -42.66 | -29.10 | -21.13 | 48.38 | 49.15 | 45.17 | 36.04 | -35.76 | -42.99 | -50.52 | -38.06 | -32.57 | 8.75 | 16.45 | 5.42 | 1.96 | -35.43 | -37.53 | -41.84 | -50.48 | -18.98 | -15.23 | -0.35 | 17.56 | -4.47 | - | - | - | - | - | - | - | - |
ROCE % |
-116.32 | -143.35 | -101.10 | -96.03 | -42.98 | -59.38 | -47.12 | -62.20 | -55.39 | -59.64 | -62.86 | -72.00 | -77.88 | -69.19 | -61.55 | -50.97 | -33.14 | -27.66 | 49.79 | 51.75 | 47.17 | 39.45 | -41.06 | -50.31 | -59.78 | -45.07 | -38.33 | 9.44 | 18.98 | 2.52 | -4.70 | -50.71 | -55.81 | -34.88 | -14.66 | -8.96 | 3.93 | -1.04 | -7.39 | 1.01 | - | - | - | - | - | - | - | - |
Current Ratio |
- | 4.5 | - | 2.5 | 3.1 | 4.4 | 5.7 | 5.4 | 5.7 | 5.7 | 5.7 | 5.7 | 3.8 | 3.8 | 3.8 | 3.8 | 7.8 | 7.8 | 7.8 | 7.8 | 13.8 | 13.8 | 13.8 | 13.8 | 6.8 | 6.8 | 6.8 | 6.8 | 9.0 | 9.0 | 9.0 | 9.0 | 2.9 | 2.9 | 2.9 | 2.9 | 1.0 | 1.0 | 1.0 | 1.0 | - | - | - | - | - | - | - | - |
DSO |
- | 8212.5 | - | - | - | 60.2 | 0.5 | 6980.6 | 8942.5 | 41.7 | 9.8 | 4940.5 | 505.4 | 657.0 | 134.1 | 4.0 | 105.3 | 124.4 | 684.4 | 0.7 | 1178.7 | 0.1 | 942.9 | 415.2 | 117.3 | 94.8 | 34.7 | 79.0 | 0.6 | 3.7 | 0.1 | 38.1 | 71.1 | 21.1 | 75.4 | 33.7 | 11.0 | 22.8 | 0.9 | 1.3 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | 8212.5 | - | - | - | 60.2 | 0.5 | 6980.6 | 8942.5 | 41.7 | 9.8 | 4940.5 | 505.4 | 657.0 | 134.1 | 4.0 | 105.3 | 124.4 | 684.4 | 0.7 | 1178.7 | 0.1 | 942.9 | 415.2 | 117.3 | 94.8 | 34.7 | 79.0 | 0.6 | 3.7 | 0.1 | 38.1 | 71.1 | 21.1 | 75.4 | 33.7 | 11.0 | 22.8 | 0.9 | 1.3 | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | 8212.5 | - | - | - | 60.2 | 0.5 | 6980.6 | 8942.5 | 41.7 | 9.8 | 4940.5 | 505.4 | 657.0 | 134.1 | 4.0 | 105.3 | 124.4 | 684.4 | 0.7 | 1178.7 | 0.1 | 942.9 | 415.2 | 117.3 | 94.8 | 34.7 | 79.0 | 0.6 | 3.7 | 0.1 | 38.1 | 71.1 | 21.1 | 75.4 | 33.7 | 11.0 | 22.8 | 0.9 | 1.3 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD